---
$id: https://graph.org.ai/products/commodity/51172135
$type: Product
source: UNSPSC
code: "51172135"
title: "Heptaverine"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Heptaverine

**UNSPSC Code**: 51172135
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C18H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0035H8M4YL, chemically known as n,n-dimethyl-n-(3-(8,9,10-trinorbornan-2-yliden)-3-phenylpropyl)amin but generally known as heptaverine, which bears US NIH Compound Identifier 3038460. European Medicines Agency schedules Heptaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08017MIG. The term HEPTAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). HEPTAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule heptaverine under HS 29214980 and SITC 51454. As of Q4 2014, HEPTAVERINE remains the US FDA Preferred Term for this commodity. Heptaverine bears US NLM identifiers UMLS ID C2348955 and NCI Concept Code C73166. SMILES: N(CC/C(=C1/C2CC(CC2)C1)C1CCCCC1)(C)C.

